Emerging issues related to COVID-19 vaccination in patients with cancer

Kamal S. Saini; Diogo Martins-Branco; Marco Tagliamento; Laura Vidal; Navneet Singh; Kevin Punie; Monika Lamba Saini; Isagani Chico; Giuseppe Curigliano; Evandro de Azambuja; Matteo Lambertini

doi:10.1007/s40487-021-00157-1

Emerging issues related to COVID-19 vaccination in patients with cancer

Kamal S. Saini, Diogo Martins-Branco, Marco Tagliamento, Laura Vidal, Navneet Singh, Kevin Punie, Monika Lamba Saini, Isagani Chico, Giuseppe Curigliano, Evandro de Azambuja, Matteo Lambertini

Research output: Contribution to journal › Editorial › peer-review

Abstract

Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.

Original language	English
Pages (from-to)	255-265
Number of pages	11
Journal	Oncology and Therapy
Volume	9
Issue number	2
DOIs	https://doi.org/10.1007/s40487-021-00157-1
Publication status	Published - Dec 2021

Keywords

Cancer
COVID-19
Efficacy
mRNA
SARS-CoV-2
Toxicity
Vaccine
Viral vector

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s40487-021-00157-1

Cite this

@article{1e714f93af3243e398aa3ade6beac189,

title = "Emerging issues related to COVID-19 vaccination in patients with cancer",

abstract = "Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.",

keywords = "Cancer, COVID-19, Efficacy, mRNA, SARS-CoV-2, Toxicity, Vaccine, Viral vector",

author = "Saini, {Kamal S.} and Diogo Martins-Branco and Marco Tagliamento and Laura Vidal and Navneet Singh and Kevin Punie and Saini, {Monika Lamba} and Isagani Chico and Giuseppe Curigliano and {de Azambuja}, Evandro and Matteo Lambertini",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1007/s40487-021-00157-1",

language = "English",

volume = "9",

pages = "255--265",

journal = "Oncology and Therapy",

issn = "2366-1070",

publisher = "Springer International Publishing AG",

number = "2",

}

TY - JOUR

T1 - Emerging issues related to COVID-19 vaccination in patients with cancer

AU - Saini, Kamal S.

AU - Martins-Branco, Diogo

AU - Tagliamento, Marco

AU - Vidal, Laura

AU - Singh, Navneet

AU - Punie, Kevin

AU - Saini, Monika Lamba

AU - Chico, Isagani

AU - Curigliano, Giuseppe

AU - de Azambuja, Evandro

AU - Lambertini, Matteo

PY - 2021/12

Y1 - 2021/12

N2 - Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.

AB - Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.

KW - Cancer

KW - COVID-19

KW - Efficacy

KW - mRNA

KW - SARS-CoV-2

KW - Toxicity

KW - Vaccine

KW - Viral vector

UR - http://www.scopus.com/inward/record.url?scp=85116005704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116005704&partnerID=8YFLogxK

U2 - 10.1007/s40487-021-00157-1

DO - 10.1007/s40487-021-00157-1

M3 - Editorial

AN - SCOPUS:85116005704

VL - 9

SP - 255

EP - 265

JO - Oncology and Therapy

JF - Oncology and Therapy

SN - 2366-1070

IS - 2

ER -

Emerging issues related to COVID-19 vaccination in patients with cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this